Clinical Trial

Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention

Name: Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention — clinical trial record (NCT07156591)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

A prospective, single-center, observational study to compare the risk of gastric retention between the exposure group (with neuropathy) and non-exposure group (without neuropathy) in diabetic patients receiving uninterrupted semaglutide therapy

Trial Details

NCT Number	NCT07156591
Lead Sponsor	Fudan University
Conditions	Gastric Retention
Enrollment	460 participants
Start Date	2025-09-15
Primary Completion	2028-09-15 (estimated)
Study Completion	2028-09-15 (estimated)
Updated on ClinicalTrials.gov	2025-09-05